Brief: AroCell Study Shows Elevated Levels Of Serum TK1 In Hodgkin Lymphoma Patients

IDL Diagnostics AB (publ)

25/08/2021 09:38

Aug 25 (Reuters) - AroCell AB (publ)  AROC.ST :
    * ELEVATED LEVELS OF SERUM TK1 IN HODGKIN LYMPHOMA PATIENTS
    * STUDY SHOWED THAT PATIENTS WITH HODGKIN'S LYMPHOMA HAVE
SIGNIFICANTLY HIGHER CONCENTRATIONS OF TK1 WITH INCREASING
CONCENTRATIONS
    * STUDY ALSO SHOWED TK1 TO INCREASE DURING CHEMOTHERAPY IN
MAJORITY OF PATIENTS.

Source text for Eikon:  ID:nMFNbXMV2G 
Further company coverage:  AROC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))